Alexion Pharmaceuticals, Inc.

Swiss Life Asset Management Ltd ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

12/29/2025

Shares

22,510

Value ($000)

1,487

Weight

0.0%

2015 Q1 - 2021 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	12/29/2025	1,487	0.0%	22,510	6/30/2021
2020 Q4	12/29/2025	3,777	0.1%	24,176	12/31/2020
2020 Q3	12/29/2025	221	0.0%	1,935	9/30/2020
2020 Q2	12/29/2025	217	0.0%	1,935	6/30/2020
2019 Q4	12/29/2025	230	0.0%	2,123	12/31/2019
2019 Q2	12/29/2025	277	0.0%	2,123	6/30/2019
2019 Q1	12/29/2025	287	0.0%	2,123	3/31/2019
2018 Q3	12/29/2025	295	0.0%	2,123	9/30/2018
2018 Q2	12/29/2025	219	0.0%	1,760	6/30/2018
2017 Q4	12/29/2025	211	0.0%	1,760	12/31/2017
2016 Q1	12/29/2025	5,337	0.3%	38,338	3/31/2016
2015 Q4	12/29/2025	7,313	0.4%	38,338	12/31/2015
2015 Q3	12/29/2025	5,996	0.3%	38,338	9/30/2015
2015 Q2	12/29/2025	5,983	0.4%	33,098	6/30/2015
2015 Q1	12/29/2025	5,298	0.3%	30,574	3/31/2015